Plasma proteins and lymphatic tissue

**Plasma proteins** are a diverse group of proteins circulating in blood plasma, including albumin, immunoglobulins, clotting factors, transport proteins, acute phase proteins, and oncofetal proteins. They are primarily synthesized by the liver (except for immunoglobulins, which are produced by plasma cells derived from lymphoid tissue) and perform functions such as transport of substances, immune defense, hemostasis, and acute phase/inflammatory responses[1][7][8]. **Lymphatic tissue** refers to collections of lymphoid cells and structures (primary: bone marrow, thymus; secondary: lymph nodes, spleen, MALT, etc.) involved in the generation, maturation, and function of immune cells such as T and B lymphocytes[2][6][7][9]. **Plasma proteins and lymphatic tissue** are collectively critical for immune surveillance and fluid homeostasis. However, this phrase does not denote a single molecular target, receptor, or protein, but rather encompasses two large, functionally intertwined biological systems involved in immunity, hemostasis, and tissue fluid regulation[1][2][7][8]. **Summary of issues:** - The name “Plasma proteins and lymphatic tissue” is much too broad, is not a therapeutic target, and contains multiple different molecular species and tissue types. - Structured information should focus on specific plasma proteins (e.g., albumin, immunoglobulin G) or defined receptors or molecular complexes within lymphatic tissue (such as “CD20” on B cells, “Lymphotoxin beta receptor,” etc.), not on these umbrella categories.